Andreas Pharma Private Limited

Andreas Pharma Private Limited - pharma in Vasai, Maharashtra, India. FY 2026 financials & compliance.
CIN U36999MH2017PTC300287 Incorporated 29 September 2017 ROC Mumbai HQ Vasai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹13.12 Cr
▲ 63% YoY
Net profit · FY 2024
₹16.38 Lakh
Net margin 1.2%
EBITDA · FY 2024
₹16.38 Lakh
EBITDA margin 1.2%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹2.05 Cr
Satisfied ₹60 Lakh
Company age
9 yrs
Est. 2017
Directors on board
5
As per MCA filings

About Andreas Pharma Private Limited

Data last updated:

Andreas Pharma Private Limited is a private limited company based in Vasai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 September 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U36999MH2017PTC300287. Its GSTIN is 27AAQCA0900J1ZQ (Maharashtra).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Ashish Jagtamba Singh and Saurabh Kumar Singh.

Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vasai, Maharashtra.

As per the financials filed for FY 2024, the company reported a revenue of ₹13.12 Cr, a growth of 63% compared to the previous year. For the same year it recorded a net profit of ₹16.38 Lakh (net margin 1.2%) and EBITDA of ₹16.38 Lakh (EBITDA margin 1.2%).

As per MCA filings, the company has open charges of ₹2.05 Cr and satisfied charges of ₹60 Lakh on record. Court records list 3 cases involving the company, including 3 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website andreaspharma.com.

Company Details of Andreas Pharma Private Limited
CIN U36999MH2017PTC300287
Registration Number 300287
Incorporation Date 29 September 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Gala No.206 B – 1, Prime Trade Center Ind.Est, Vasai, Maharashtra, India – 401208
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Andreas Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Andreas Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Andreas Pharma Private Limited in one report.

Financials from FY 2018 Directors & ownership Charges & compliance

Business Activity of Andreas Pharma Private Limited

The main business activity of Andreas Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Andreas Pharma Private Limited FY 2025 filings available

Andreas Pharma Private Limited reported revenue of ₹13.12 Cr (up 63% YoY) for FY 2024.

Revenue · FY 2024
₹13.12 Cr ▲ 63%
Net profit · FY 2024
₹16.38 Lakh margin 1.2%
EBITDA · FY 2024
₹16.38 Lakh margin 1.2%

Compounded Annual Growth Rate (CAGR) of Andreas Pharma Private Limited

Revenue CAGR growth
1 year
▲ 63%
EBITDA CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 591%
5 years · compounded
▲ 219%

Revenue rose 63% in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Andreas Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹16.38 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹16.38 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Andreas Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin1.2%••••••••••••••••
Net Profit Margin1.2%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Andreas Pharma are in the company report.

Premium access

Financial statements from FY 2018

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Andreas Pharma Private Limited

Andreas Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vincit Biotech International Private Limited₹13.14 Cr (FY 2025)••••••••-13.0%••••Indore, Madhya Pradesh, India
Wynclark Pharmaceuticals Private Limited₹13.13 Cr (FY 2025)••••••••-70.0%••••Hyderabad, Telangana, India
Modi Remedies Private Limited₹13.12 Cr (FY 2025)••••••••35.0%••••Cuttack, Odisha, India
Sitra Biotech Private Limited₹13.12 Cr (FY 2022)••••••••54.0%••••New Delhi, Delhi, India
Knoll Pharmaceuticals Limited₹13.12 Cr (FY 2025)••••••••124.0%••••Badli, Delhi, India
Andreas Pharma Private Limited this company₹13.12 Cr (FY 2024)••••••••63.0%••••Vasai, Maharashtra, India
M B and K Pharma Private Limited₹13.11 Cr (FY 2025)••••••••3.0%••••Varanasi, Uttar Pradesh, India
Aakanksha Logistics Private Limited₹13.11 Cr (FY 2025)••••••••4.0%••••Pune, Maharashtra, India
Kaps Three Life Sciences Private Limited₹13.11 Cr (FY 2024)••••••••6.0%••••Surendranagar, Gujarat, India
Merit Polychem Pvt. Ltd.₹13.11 Cr (FY 2025)••••••••-7.0%••••Kolkata, West Bengal, India
Guided Gateway Private Limited₹13.1 Cr (FY 2025)••••••••30.0%••••Sankrail, West Bengal, India

Peers are the five companies nearest above and the five nearest below Andreas Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Andreas Pharma Private Limited

Andreas Pharma Private Limited is audited by AJAY SHUKLA & ASSOCIATES for the financial year 2023.

NameStatusAppointment DateCessation Date
AJAY SHUKLA & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Andreas Pharma Private Limited

Andreas Pharma has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ashish Jagtamba SinghDirector29 Sep 20179 Years 0 MonthsCurrent
Saurabh Kumar SinghDirector27 Dec 20196 Years 9 MonthsCurrent
Ujjwal Nityanand JhaDirector15 Feb 20224 Years 7 MonthsCurrent
Indraraj NeogiDirector15 Feb 20224 Years 7 MonthsCurrent
Vinay Kumar SinghDirector27 Dec 20196 Years 9 MonthsCurrent

Ownership and Shareholding of Andreas Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Andreas Pharma Private Limited

Open charges
₹2.05 Cr
Satisfied charges
₹60 Lakh
Breakdown by lending institutions
Others₹2.05 Cr
Latest charge details
DateLenderAmountStatus
03 Oct 2024Others₹2 CrOpen
31 Oct 2023Others₹5.2 LakhOpen
26 Jul 2023Hdfc Bank Limited₹60 LakhSatisfied

Total charge records: 3 View all charges

Employees and EPFO Compliance at Andreas Pharma Private Limited

Employment history and EPFO contributions of people linked to Andreas Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Andreas Pharma Private Limited

Andreas Pharma Private Limited has 8 board changes on record since 2017: 5 appointments and 3 cessations. The latest: Indraraj Neogi was appointed as Director on 15 Feb 2022.

Charges
A charge registered on 26 Jul 2023 via Charge ID 100773725 with Hdfc Bank Limited was fully satisfied on 10 Nov 2025.
AGM
Andreas Pharma Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Filing
Andreas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 101017621 was registered on 03 Oct 2024.
Charges
A charge with Others amounted to Rs. 5.20 Lakh with Charge ID 100817148 was registered on 31 Oct 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 60.00 Lakh with Charge ID 100773725 was registered on 26 Jul 2023.
Appointed
Indraraj Neogi was appointed as Director.
Appointed
Ujjwal Nityanand Jha was appointed as Director.
Ceased
Sandip Gangopadhyay ceased to be Director.
Ceased
Ajeya Kumar ceased to be Additional Director.
Appointed
Saurabh Kumar Singh was appointed as Director.
Ceased
Ved Prakash Singh ceased to be Director.

3 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Andreas Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Andreas Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Andreas Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Andreas Pharma Private Limited

Andreas Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAQCA0900J1ZQMaharashtraActive29 Mar 2022
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Andreas Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Andreas Pharma Private Limited

Andreas Pharma is an active private limited company based in Vasai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 September 2017 (9+ years old) and is registered under CIN U36999MH2017PTC300287.

Andreas Pharma reported revenue of ₹13.12 Cr for FY 2024 (up 63% YoY).

Andreas Pharma has 5 current directors:

Andreas Pharma reported a net profit of ₹16.38 Lakh (net margin 1.2%) and EBITDA of ₹16.38 Lakh (EBITDA margin 1.2%) for FY 2024, as per its filed financial statements.

The GSTIN of Andreas Pharma is 27AAQCA0900J1ZQ, registered in Maharashtra.

The CIN (Corporate Identification Number) of Andreas Pharma is U36999MH2017PTC300287. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Andreas Pharma has 3 court cases on record: 3 filed against it.

Andreas Pharma was incorporated on 29 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Andreas Pharma by revenue are Vincit Biotech International Private Limited, Wynclark Pharmaceuticals Private Limited, Modi Remedies Private Limited, Sitra Biotech Private Limited, Knoll Pharmaceuticals Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Indraraj Neogi was appointed as Director on 15 Feb 2022. Ujjwal Nityanand Jha was appointed as Director on 15 Feb 2022. Sandip Gangopadhyay ceased to be Director on 17 Feb 2021. Andreas Pharma has 8 board changes on record in total.

Andreas Pharma can be reached through the website andreaspharma.com. Its registered office is in Vasai, Maharashtra, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available